TD Asset Management
ROIV icon

TD Asset Management’s Roivant Sciences ROIV Stock Holding History

TD Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.7M Sell
386,882
-328,400
-46% -$9.7M 0.01% 587
2026
Q1 		$19.8M Buy
715,282
+163,906
+30% +$4.21M 0.02% 508
2025
Q4 		$12M Buy
551,376
+235,176
+74% +$4.64M 0.01% 611
2025
Q3 		$4.78M Buy
316,200
+153,800
+95% +$1.9M ﹤0.01% 796
2025
Q2 		$1.83M Buy
+162,400
New +$1.76M ﹤0.01% 964
2024
Q2 		– Sell
-91,192
Closed -$961K – 1419
2024
Q1 		$961K Sell
91,192
-402,892
-82% -$4.34M ﹤0.01% 1173
2023
Q4 		$5.55M Sell
494,084
-725,496
-59% -$7.07M 0.01% 739
2023
Q3 		$14.2M Buy
+1,219,580
New +$13.8M 0.02% 507

Other funds holding ROIV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $646M AUM 291.07% 1-Year Est. Return

TD Asset Management's ROIV Position: Q2 2026 in Review

TD Asset Management reduced its Roivant Sciences (ROIV) stake by 46% in Q2 2026, selling an estimated $9.7M and leaving 386,882 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #587.

TD Asset Management first reported a position in ROIV in Q3 2023 and has held it in 8 quarters since. The position peaked at $19.8M in Q1 2026. 357 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • TD Asset Management held 386,882 shares of Roivant Sciences worth $13.7M as of Q2 2026.
  • TD Asset Management sold 328,400 Roivant Sciences shares in Q2 2026, an estimated $9.7M.
  • Roivant Sciences made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #587 holding.
  • TD Asset Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 8 quarters since.
  • TD Asset Management's Roivant Sciences position peaked at $19.8M in Q1 2026.
  • 357 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.